Drug Patents owned by Santen

1. Drug name - VERKAZIA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9956289 SANTEN Emulsion compositions containing quaternary ammonium compounds Jan, 2026

(3 years from now)

US9220694 SANTEN Emulsion compositions containing cetalkonium chloride Jan, 2026

(3 years from now)

US7973081 SANTEN Emulsion compositions containing quaternary ammonium compounds Jan, 2026

(3 years from now)

US8524779 SANTEN Emulsion compositions containing quaternary ammonium compounds Jan, 2026

(3 years from now)

US8298568 SANTEN Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential Nov, 2027

(5 years from now)

US9132071 SANTEN Compositions containing quaternary ammonium compounds Jun, 2029

(6 years from now)

Drugs and Companies using CYCLOSPORINE ingredient

Treatment: NA

Dosage: EMULSION;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.1% EMULSION;OPHTHALMIC Prescription

availability in other generic markets.

Click on the highlighted region to filter.